23.6 C
New York
Saturday, May 28, 2022

Asensus Surgical Inc (TRXC) stock is on the rise after FDA clearance, why?

Asensus Surgical Inc (TRXC)‎ stock is on a headway after the company announced that they have received an additional FDA clearance for the Senhance Surgical system. Asensus Surgical Inc (TRXC) is a medical device company working on improving the process of surgery by digitizing the interface between surgeon and patient. This will be the beginning of a more advanced and reliable era of performance guided surgery. 


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Recent development

Senhance surgical system is the digital laparoscopic platform that allows augmented intelligence which shows great performance and patient outcomes through machine learning. Senhance surgical is first of its kinds, while its most important function is indication expansion in general surgery. Enhancing and improving the process of general surgery in USA, Senhace surgical system provides surgical assurance through,

  • haptic feedback
  • eye tracking camera control
  • 3D visualization

This new system goes ahead of the typical surgical robotic systems and is the first platform to offer 3mm instruments i-e the most precise instrument available in the world to perform robotic surgery.

The CEO of the company says that through Senhance surgical system they have achieved a major milestone towards the growth and clinical applicability of their technology. This system is an expansion into general surgery which is the largest area of manual laparoscopy that can benefit from the accuracy of performance guided surgery.

The indication expansion in Senhance surgical system makes it extremely convenient to be used in many high value and complex reconstructive surgeries like the ones used to treat reflux and obesity. The system can be used in over 2.7 million general surgical procedures, performed annually.

Upcoming Event

The company also announced that the CEO and Vice president of Asensus surgical will be participating in the H.C Virtual Global Life Sciences Conference happening on the 9th and 10th of March.

These recent developments have caused TRXC stock to rise because not just for the company but it is extremely beneficial for the whole surgical system in USA.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles